Navigation Links
Drug Failed to Reduce Heart Attack Risk After Bypass
Date:4/1/2008

MC-1 had no benefit for postoperative stroke, atrial fibrillation or kidney function

TUESDAY, April 1 (HealthDay News) -- Researchers found that giving patients MC-1, a naturally occurring metabolite of vitamin B6, before and after bypass surgery didn't reduce the risk of heart attack or cardiovascular death.

"Coronary artery bypass graft (CABG) surgery is one of the most important therapeutic options for relieving angina and improving survival and quality of life in patients with multi-vessel coronary artery disease," the Duke University scientists wrote. "It is the most commonly performed cardiac surgical procedure in the world, and, in 2005, more than 250,000 CABG procedures were performed in the United States."

But CABG surgery can lead to serious complications such as heart attack, recurrent angina, kidney problems, stroke and death. Previous research suggested that MC-1 may lower the risk of heart attack or death in high-risk patients.

A new phase 3 multi-center, randomized trial of MC-1 included 3,023 intermediate- to high-risk patients undergoing CABG surgery with cardiopulmonary bypass. It found that cardiovascular death or nonfatal heart attack 30 days after surgery occurred in 140 of 1,510 patients (9.3 percent) who received MC-1 and in 133 of 1,486 patients (9.0 percent) who received a placebo.

All-cause death was 1 percent in the MC-1 group and 0.3 percent in the placebo group at four days, and 1.9 percent in the MC-1 group and 1.5 percent in the placebo group at 30 days.

Both groups had similar levels of postoperative stroke, atrial fibrillation, kidney function, and intensive care unit and hospital lengths of stay.

The findings show that "among intermediate- to high-risk patients undergoing CABG surgery, MC-1, 250 mg/d, given immediately before and for 30 days following surgery did not reduce cardiovascular death or nonfatal (heart attack)," the study authors wrote. "My
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed
2. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
3. Fallout From Failed AIDS Vaccine Could Dampen Research
4. Safe, Green Insecticides Can Reduce Chemical Exposure in Homes and Gardens
5. Illinois Radiologists Self-Edit Reports, Reduce Turnaround Time with SpeechQ for Radiology(TM)
6. Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
7. Psychological intervention reduces postembolization pain
8. Aspirin Reduces Asthma Risk Among Older Women
9. Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs
10. Low-Fat Dairy Reduces High Blood Pressure Risk
11. Late treatment with letrozole can reduce breast cancer recurrence risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Failed to Reduce Heart Attack Risk After Bypass 
(Date:8/21/2014)... 2014 Top10BestSEOHosting.com has recently compared ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one of the ... , The manager of Top10BestSEOHosting.com states, “It is ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 An increasing ... a taxpayer that their federal tax payment is being ... appears to come from the IRS, “tax@irs.gov”, it’s actually ... provide personal and financial information. , While similar scams ... an uptick in phishing activity is occurring right now. ...
(Date:8/21/2014)... Patients with advanced laryngeal cancer appear to have ... than nonsurgical chemoradiation. , Author: Uchechukwu C. Megwalu, ... at Mount Sinai, New York, and colleagues. , ... cancer are diagnosed each year and squamous cell ... tumors. Prior to 1991, total surgical removal of ...
(Date:8/21/2014)... at a low or very low birth weight may ... diabetes. The findings, which appear in Diabetes Care ... type 2 diabetes in African American populations, which has ... from Boston University,s Slone Epidemiology Center followed more than ... over the course of 16 years, analyzing characteristics such ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Among seniors, dimming vision ... The study involved more than 2,500 people, aged 65 to ... and again two, six and eight years later. Vision ... person,s risk of death during the study period, the researchers ... researchers led by Sharon Christ of Purdue University in West ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... Service Helps Providers Better Partner with Patients in ... Deepening its commitment to empowering patients and ... & Associates, LLC, a firm of strategic healthcare ... has established a new, first-of-its-kind service called Patient ...
... New Orleans, LA Xiaoming, Xu, PhD, Associate ... Health Sciences Center New Orleans School of Dentistry, ... of $1.77 million over four years by the ... fluoride-releasing, and bioactive dental materials including dental composites, ...
... Fla.--A new blood test used in combination with a ... of prostate cancer diagnosis, and could eliminate tens of ... according to a study led by researchers at Dana-Farber ... American Society of Clinical Oncology in Orlando, Fla., William ...
... Estimator(TM) Gives Patients Visibility into Treatment Costs before ... with the high number of uninsured and underinsured ... in consumer-driven health plans, such as Health Savings ... their own healthcare costs. As a result, hospitals ...
... Now, no matter when a patient with the ... a Spanish-speaking representative is available to help. Insulet Corporation ... insulin pump technology with its OmniPod System, has expanded ... a day, seven days a week."Managing diabetes is a ...
... NEW YORK, May 28 A new history of shock ... They Don,t Want You to Know About Shock Treatment" ( ... the Food and Drug Administration,s failure to investigate the devices ... is timely due to the FDA,s recent decision to call ...
Cached Medicine News:Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 2Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 3Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 4Health News:New blood test greatly reduces false-positives in prostate cancer screening 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 3Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 4Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 2Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 3Health News:New Book Highlights Human Cost of FDA's Failure to Investigate Medical Devices 2
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health ... Cancer Center today announced a new partnership to provide ... of community breast care centers in the greater ... MD Anderson will become the exclusive provider of professional breast ... centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Shannon Hartley Shines in PharmaVOICE 100 2DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... outsourcing company with operations in China and the United ... for the second quarter of 2011 after the New ... (which will be Thursday morning, August 11, 2011 Shanghai ...
... For the fourth year, the Fondation,Médéric Alzheimer and ... psychosocial,interventions for people with dementia and their carers. The,purpose ... share best,practices. Applications can be submitted from today 19 ... . Psychosocial research involves or relates to ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 24th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care 2
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps : Eckardt End & Side Gripping Forceps...
Medicine Products: